Denteric Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14.1M
- Investors
-
5
Denteric General Information
Description
Developer of a biotechnology platform designed to create vaccines for treating periodontal diseases. The company's platform develops vaccines against virulence factors produced by the bacterium Porphyromonas gingivalis and other related species that cause multiple diseases, enabling patients to get cured of dental diseases and their complications.
Contact Information
Website
www.denteric.comCorporate Office
- Level 9
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Corporate Office
- Level 9
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Denteric Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 26-Sep-2019 | $14.1M | Completed | Generating Revenue |
Denteric Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Denteric Comparisons
Industry
Financing
Details
Denteric Competitors (1)
One of Denteric’s competitors is Allele Biotechnology, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Allele Biotechnology | Venture Capital-Backed | San Diego, CA |
Denteric Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Denteric Patents
Denteric Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024904254-A0 | Methods of treatment using vaccine compositions | Pending | 20-Dec-2024 | ||
| AU-2023902382-A0 | Methods of treatment | Inactive | 26-Jul-2023 | ||
| AU-2023902373-A0 | Chimeric protein vaccine | Inactive | 26-Jul-2023 | ||
| AU-2023902379-A0 | Rna vaccines | Inactive | 26-Jul-2023 | ||
| AU-2023902376-A0 | Rna vaccines for use in animal health | Inactive | 26-Jul-2023 |
Denteric Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brandon Biocatalyst | Venture Capital | Minority | ||
| Brandon Capital | Venture Capital | Minority | ||
| CSL | Corporation | Minority | ||
| The University of Melbourne Endowment | Limited Partner | Minority | ||
| United News of India | Corporation | Minority |
Denteric FAQs
-
When was Denteric founded?
Denteric was founded in 2019.
-
Where is Denteric headquartered?
Denteric is headquartered in Melbourne, Australia.
-
What industry is Denteric in?
Denteric’s primary industry is Drug Discovery.
-
Is Denteric a private or public company?
Denteric is a Private company.
-
What is the current valuation of Denteric?
The current valuation of Denteric is .
-
What is Denteric’s current revenue?
The current revenue for Denteric is .
-
How much funding has Denteric raised over time?
Denteric has raised $14.1M.
-
Who are Denteric’s investors?
Brandon Biocatalyst, Brandon Capital, CSL, The University of Melbourne Endowment, and United News of India have invested in Denteric.
-
Who are Denteric’s competitors?
Allele Biotechnology is a competitor of Denteric.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
